Literature DB >> 12957880

Treatment of adynamia in aphasia.

Anastasia M Raymer1.   

Abstract

Transcortical motor aphasia (TCMA) is an acquired impairment of language expression that occurs following neurologic damage that affects left frontal cortex and spares perisylvian regions. In some individuals with TCMA, verbal expression is rendered nonfluent due to difficulty spontaneously initiating and elaborating upon verbal messages. Nonfluency arises from impaired activation of intended messages and inhibition of competing verbal expressions. This impairment of the intentional aspects of language expression can be termed 'adynamia.' Because adynamic forms of TCMA occur infrequently, few systematic treatment investigations have been reported for this condition. Behavioral treatments have been proposed to engage intact frontal regions to improve the ability to initiate spontaneous verbal expression. Some data suggest that nonsymbolic limb movements performed in the context of speaking activities, a form of what Luria termed gestural reorganization, may improve the adynamic verbal expression. (1) In addition, the influence of pharmacologic treatment with bromocriptine, a dopaminergic agonist, has been considered for its effects on verbal nonfluency in aphasia. Individuals classified as TCMA are more likely to benefit than those with other forms of nonfluent aphasia, suggesting an influence of bromocriptine on circuits necessary to activate spontaneous language. Additional studies are warranted that contrast behavioral and pharmacologic interventions to determine optimal conditions to improve verbal expression in adynamic forms of aphasia.

Entities:  

Mesh:

Year:  2003        PMID: 12957880     DOI: 10.2741/1142

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  6 in total

Review 1.  Poststroke aphasia : epidemiology, pathophysiology and treatment.

Authors:  Marcelo L Berthier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

Review 3.  Neuroscience insights improve neurorehabilitation of poststroke aphasia.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller
Journal:  Nat Rev Neurol       Date:  2011-02       Impact factor: 42.937

4.  Amantadine for adynamic speech: possible benefit for aphasia?

Authors:  Anna M Barrett; Paul J Eslinger
Journal:  Am J Phys Med Rehabil       Date:  2007-08       Impact factor: 2.159

Review 5.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

6.  Aphasia therapy on a neuroscience basis.

Authors:  Friedemann Pulvermüller; Marcelo L Berthier
Journal:  Aphasiology       Date:  2008-05-21       Impact factor: 2.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.